← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:713 | 713 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2001 | 73013-2001-2 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:713 | 713 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6382 | 72934-6382-2 | Hydroquinone; Tretinoin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:713 | 713 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:713 | 713 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:713 | 713 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:713 | 713 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5550 | 72934-5550-2 | Lidocaine; Mupirocin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:713 | 713 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:714 | 714 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5230 | 71266-5230-1 | Phenylephrine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronidase | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-27 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6627 | 71300-6627-2 | Ketoprofen | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2001 | 73013-2001-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6380 | 72934-6380-2 | Hydroquinone; Tretinoin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:714 | 714 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-175 | 70092-175-46 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5536 | 72934-5536-4 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:714 | 714 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-846 | 54288-846-10 | Liraglutide | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:715 | 715 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-009 | 81375-009-05 | Prednisolone/Bromfenac | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:715 | 715 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0457 | 5446-0457-03 | Hydrocortisone; Chloramphenicol; Sulfamethoxazole; Amphotericin B | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:715 | 715 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:715 | 715 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Guaifenesin | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-1 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6392 | 72934-6392-2 | Hydroquinone; Tretinoin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-527 | 65302-527-15 | Ketorolac Tromethamine; Bupivacaine Hydrochloride; Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-443 | 70092-443-43 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-4 | Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:715 | 715 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-151 | 73198-151-05 | Liraglutide | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:716 | 716 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl and Bupivacaine | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:716 | 716 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:716 | 716 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3349 | 62295-3349-1 | Hydromorphone | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:716 | 716 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-947 | 69374-947-50 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Racepinephrine Hydrochloride; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:716 | 716 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6388 | 72934-6388-2 | Hydroquinone; Tretinoin; Hydrocortisone | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-681 | 70092-681-50 | Ketorolac Tromethamine; Racepinephrine Hydrochloride; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-909 | 69194-909-01 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:716 | 716 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-2 | Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:716 | 716 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-151 | 73198-151-10 | Liraglutide | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:717 | 717 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3012 | 79559-3012-1 | S-E012.5 | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:717 | 717 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Racepinephrine Hydrochloride; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-908 | 69194-908-01 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-144 | 82396-144-05 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-307 | 69852-307-45 | Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:717 | 717 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0061 | 81483-0061-0 | Lorazepam | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:718 | 718 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6010 | 72196-6010-1 | Rocuronium 10mg/ml | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-562 | 72833-562-30 | Glutathione | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1435 | 72934-1435-2 | Ibuprofen; Salicylic Acid | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-443 | 70092-443-43 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:718 | 718 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:718 | 718 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:719 | 719 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | ESTRADIOL 12.5 PEL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione; Ascorbic Acid; Zinc Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-050 | 71170-050-05 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4235 | 72934-4235-9 | Ibuprofen; Terbinafine Hydrochloride; Fluconazole; Itraconazole | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:719 | 719 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5535 | 72934-5535-4 | Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:719 | 719 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:720 | 720 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1583 | 72934-1583-2 | Alomira | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-2 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-526 | 65302-526-10 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:720 | 720 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-204 | 69852-204-45 | Lidocaine; Tetracaine; Benzocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:720 | 720 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Loteprednol Etabonate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:721 | 721 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-946 | 69374-946-34 | Labetalol Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:721 | 721 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6006 | 72196-6006-1 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5537 | 72934-5537-4 | Lidocaine; Tetracaine; Benzocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:721 | 721 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:722 | 722 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-020 | 71449-020-15 | Epinephrine | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1486 | 5446-1486-01 | Glycerin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-1 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-009 | 70092-009-44 | Labetalol Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-009 | 70092-009-44 | Labetalol Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:722 | 722 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:722 | 722 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:723 | 723 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-50 | Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8610 | 71266-8610-1 | Glycerin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-05 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:723 | 723 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:723 | 723 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-5974 | 72682-5974-1 | Lysine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:724 | 724 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-25 | Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:724 | 724 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:724 | 724 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:724 | 724 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Epinephrine; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-985 | 69374-985-05 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:724 | 724 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5575 | 26436-5575-3 | Inositol; Cyanocobalamin; Choline Chloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:724 | 724 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-0 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-606 | 81375-606-05 | Liraglutide | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:724 | 724 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-077 | 73198-077-30 | Lysine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:725 | 725 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-443 | 70092-443-43 | Lido 1% Bicarb PF 1 ml-3 ml syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:725 | 725 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:725 | 725 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Human Chorionic Gonadotropin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-07 | Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:725 | 725 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:725 | 725 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-614 | 81375-614-06 | Liraglutide | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:725 | 725 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:726 | 726 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | 625 CALCIUM CHLORIDE 20MG/ML BAG | 2025-1 | valid | 0 | 2026-09-18 |